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Objectives This study aimed at determining the prevalence of epicardial and microvascular coronary spasm in patients with
anginal symptoms, despite angiographically normal coronary arteries.
Background Despite a typical clinical presentation with exercise-related anginal symptoms (chest pain or dyspnea) with or
without occasional attacks of resting chest pain suggestive of coronary artery disease, 40% of patients undergo-
ing diagnostic angiography have normal or “near” normal coronary arteriograms. Many of these patients are
given a diagnosis of noncardiac chest pain, and some are considered to have microvascular angina. However,
we speculate that abnormal coronary vasomotion (reduced vasodilatation with exercise  reduced coronary flow
reserve and/or vasospasm at rest) might also represent a plausible explanation for the symptoms of the patient.
Methods This was a prospective study in 304 consecutive patients (50% men, mean age 66  10 years) with exertional
anginal symptoms undergoing diagnostic angiography. A total of 139 patients (46%) had 50% coronary artery
disease in at least 1 coronary artery, 21 patients (7%) had luminal narrowings ranging from 20% to 49%, and
144 patients (47%) had normal coronary arteries or only minimal irregularities (20% diameter reduction).
Results One hundred twenty-four patients of the latter (86%) underwent intracoronary acetylcholine (ACH) testing, which
elicited coronary spasm in 77 patients (62%), 35 patients (45%) with epicardial spasm (75% diameter reduc-
tion with reproduction of the symptoms of the patient) and 42 patients (55%) with microvascular spasm (repro-
duction of symptoms, ischemic electrocardiographic changes, and no epicardial spasm).
Conclusions Nearly 50% of patients undergoing diagnostic angiography for assessment of stable angina had angiographically
normal or near normal coronary arteriograms. The ACH test triggered epicardial or microvascular coronary
spasm in nearly two-thirds of these patients. Our results suggest that abnormal coronary vasomotion plays a
pathogenic role in this setting and that the ACH test might be useful to identify patients with cardiac symptoms,
despite normal coronaries. (Abnormal Coronary Vasomotion in Patients With Suspected CAD But Normal Coro-
nary Arteries; NCT00921856) (J Am Coll Cardiol 2012;59:655–62) © 2012 by the American College of
Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.015Recent studies have shown that approximately 40% of
patients undergoing diagnostic coronary angiography for
typical exertional chest pain (i.e., stable angina) have com-
pletely normal arteries or nonobstructive coronary artery
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2011, accepted November 1, 2011.disease (CAD) (1–3). The presence of normal or near-
normal coronary arteriograms often leads the managing
physician to make a diagnosis of noncardiac chest pain.
See page 663
However, cardiac mechanisms such as increased coronary
artery vasomotion (i.e., epicardial or microvascular coronary
spasm) (4,5) and/or abnormal coronary microvascular
vasodilatory function, as seen in patients with microvascular
angina (6), can be responsible for the occurrence of anginal
symptoms in these patients. Indeed, several studies have
s656 Ong et al. JACC Vol. 59, No. 7, 2012
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cardial and abnormal microvas-
cular vasomotor responses can
lead to myocardial ischemia in pa-
tients without atherosclerotic cor-
onary artery obstructions (7–10).
It is not known, however, how
often this mechanism can explain
the presence of anginal symp-
toms in individuals referred to
diagnostic angiography for the
assessment of stable angina who
are found to have nonobstructive CAD or completely
normal coronary arteriograms. Therefore, the present study
sought to assess the prevalence of epicardial and microvas-
cular coronary spasm among patients presenting with stable
anginal symptoms but who had angiographically normal
coronary arteries or only minimal irregularities (20%
narrowings).
Methods
Patients. The present study, ACOVA (Abnormal COronary
VAsomotion in patients with stable angina and unob-
structed coronary arteries), is a prospective trial involving
376 consecutive patients undergoing diagnostic coronary
angiography between December 2007 and December 2008,
Abbreviations
and Acronyms
ACH  acetylcholine
CAD  coronary artery
disease
ECG  electrocardiogram/
electrocardiographic
LCA  left coronary artery
RCA  right coronary
artery
Figure 1 Study Flow Chart
The flow chart visualizes the number of patients in the respective groups accordin
in patients with normal or “near” normal coronary arteries. CAD  coronary arteryfor the assessment of stable angina pectoris. For inclusion in
the study, patients had to have exercise-related anginal
symptoms suggestive of CAD (chest pain or dyspnea, with
or without occasional attacks of resting chest pain) and a left
ventricular ejection fraction 50%, as assessed by left
ventriculography. Patients with acute coronary syndrome,
valvular heart disease, cardiomyopathy, myocarditis, chronic
obstructive pulmonary disease, chronic renal failure, or a
history of dysphagia or gastroesophageal reflux were not
included in the study. Furthermore, we excluded patients
with a history compatible with Prinzmetal’s variant angina
(i.e., purely rest angina, despite a preserved exercise capacity,
and documented transient ST-segment elevation during
chest pain, relieved spontaneously or by nitrates and/or
angiographic evidence of focal coronary spasm). Traditional
cardiovascular risk factors, including hypertension, diabetes,
hypercholesterolemia, current cigarette smoking, and a pos-
itive family history for cardiovascular disease (i.e., myocar-
dial infarction or stroke in a first-degree relative 65 years
of age), were recorded in every patient.
Three hundred four patients (80%) were found to be
eligible for inclusion in the study. They were divided into 3
groups according to the degree of epicardial narrowing on
angiography: Group 1: 0% to 20% narrowings (n  144),
Group 2:50% stenosis (n 139), Group 3:20% to 49%
tenosis (n  21) (Fig. 1). Our study focused on groups 1
e degree of epicardial stenosis and the result of the acetylcholine (ACH) test
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men; mean age 66  10 years), of whom 240 (85%)
nderwent exercise stress testing before angiography, which
howed ischemic electrocardiographic (ECG) changes in
51 (53%) patients. The remainder underwent diagnostic
oronary angiography on the basis of a high pre-test likelihood
or obstructive CAD. The study complied with the Declara-
ion of Helsinki, and the study protocol was approved by the
ocal ethics committee. All patients gave written informed
onsent before study entry. Trial registry information is given
fter abstract.
tudy protocol. The study flowchart is shown in Figure 1.
atients with normal coronary arteries or only minimal
rregularities on baseline diagnostic angiography (Group 1)
nderwent standardized intracoronary acetylcholine (ACH)
rovocation for the assessment of coronary vasomotor func-
ion (ACH test). We have previously reported our standard-
zed procedure for the assessment of coronary vasomotor
bnormalities in our institution (4,11). As per our institu-
ional protocol, cardiovascular medications able to affect
oronary vasomotor responses (calcium channel blockers,
eta blockers, long acting nitrates) were discontinued at
east 24 h before coronary angiography. Sublingual glyceryl
rinitrate administration, however, was permitted for the
elief of chest pain at all times. None of the patients required
his treatment 4 h before angiography.
Incremental doses of ACH 2, 20, 100, and 200 g
11,12) were administered over a period of 3 min each into
he left coronary artery (LCA) via the angiographic catheter.
n the patients who did not develop symptoms or ischemic
CG changes, we subsequently injected ACH into the
ight coronary artery (RCA) (80 g ACH over 3 min).
fter the administration of ACH or when chest pain and/or
oronary spasm developed, 0.2 mg glyceryl trinitrate (Per-
inganit, Schwarz Pharma, Monheim, Germany) were in-
ected into both the LCA and RCA. Heart rate, blood
ressure, and the 12-lead-ECG were continuously moni-
ored during ACH testing.
easurements. The angiographic images were quantita-
ively analyzed with QCA-CMS (version 7.0, Medis-
oftware, Leiden, the Netherlands). The following binary
ariables were obtained for analysis: reproduction of the
sual chest pain of the patient, presence of coronary vaso-
onstriction 75%, and ischemic ECG changes (i.e., ST-
egment depression or ST-segment elevation of 0.1 mV
r T-wave peaking in at least 2 contiguous leads).
Both the location and type of epicardial spasm (i.e., focal
s. diffuse) were also assessed (13). “Focal” spasm was
efined as a circumscribed transient vessel narrowing within
he borders of 1 isolated coronary segment as defined by the
merican Heart Association (13). “Diffuse” spasm was
iagnosed when the vessel narrowing was observed in 2
djacent coronary segments. Proximal spasm was defined as
asoconstriction occurring in segments 1, 5, 6, or 11.
id-vessel spasm was recorded when occurring in segments
, 3, or 7, whereas distal spasm was defined as that occurring pn segments 4, 8, 9, 10, 12, 13, 14, or 15. No incidents of
atheter-induced spasms were observed.
efinition of coronary spasm on ACH testing. The
CH test was considered “positive” and indicative of
picardial coronary spasm, in the presence of 75% focal or
iffuse coronary artery diameter reduction, compared with
he relaxed state achieved with the intracoronary adminis-
ration of glyceryl trinitrate, associated with a reproduction
f the symptoms of the patient (Figs. 2A and 2B) (4). For
he definition of microvascular spasm, we used the criteria
stablished by Mohri et al. (5). Hence, in our study, we
iagnosed microvascular spasm when the injection of
CH reproduced the symptoms usually experienced by
he patient and triggered ischemic ECG changes (i.e.,
T-segment depression or ST-segment elevation of 0.1
V or T-wave peaking in at least 2 contiguous leads), in
he absence of epicardial spasm (75% diameter reduc-
ion) (Figs. 2C and 2D) (5).
tatistical analysis. Data analysis was carried out with
PSS (version 16.0, SPSS, Inc., Chicago, Illinois). Results
re expressed as mean SD. The t test was used to compare
ontinuous variables. For values without normal distribu-
ion, median and interquartile ranges are stated, and the
ann-Whitney U test was used for analysis. The Fisher’s
xact test was used for categorical variables. After univariate
nalysis, multivariate logistic regression analysis was per-
ormed in a forward likelihood fashion to identify indepen-
ent predictors for obstructive CAD as well as abnormal
oronary vasomotion. A 2-tailed p value of 0.05 was
onsidered statistically significant.
esults
linical characteristics. The clinical characteristics of all
atients included in the study (i.e., type of anginal symp-
oms, cardiovascular risk factors, and their response to
oninvasive exercise stress testing) are shown in Table 1.
nivariate and multivariate analysis comparing patients
ith and without CAD are shown in Tables 1 and 2,
espectively. Compared with patients in Group 1, those
ith obstructive CAD (Group 2) were more likely to be
ale and older. They also had a higher prevalence of
ypercholesterolemia. In addition, they more often com-
lained of purely effort-induced chest pain than effort chest
ain or dyspnea with occasional attacks of chest pain at rest.
oreover, they showed ischemic ECG changes during non-
nvasive stress testing more often than patients in Group 1
p  0.01, respectively).
CH testing. The ACH test was performed in 124 of the
44 patients in Group 1 (86%). In 20 patients, the test could
ot be performed due to logistic reasons. There were no
erious complications during ACH testing (e.g., myocardial
nfarction, refractory spasm, sustained ventricular arrhyth-
ias, or need for resuscitation). Transient atrioventricular
lock was frequently observed and occurred mostly during
rovocation of the RCA; it always resolved within seconds
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short half-life of ACH. Coronary spasm was seen in 77
patients (62%). Thirty-five (45%) patients had epicardial
coronary spasm, and 42 had microvascular spasm (55%)
(Fig. 1).
Among patients with epicardial spasm, 30 (86%) had diffuse
and 5 (14%) had focally pronounced spasm. Epicardial spasm
was usually confined to the distal segments of the coronary
arteries (diffuse spasm in 25, and focal in 1 patient; 74%).
Proximal segment spasm was only seen in 1 patient (focal),
mid-coronary segment spasm was seen in 3 (all focal), and
spasm in all segments was seen in 5 cases (all diffuse).
Fifty-two percent of the patients with microvascular spasm
had 25% epicardial constriction during ACH-provocation.
Intermediate constriction (25% to 50% epicardial narrowing)
was seen in 36%, and the remaining 12% showed epicardial
constriction between 50% and 74%.
The ACH test was negative according to our definitions
in 47 patients (38%). Twenty-nine of these patients, how-
Figure 2 2 Representative Patients
The upper panels show left coronary artery angiograms and electrocardiograms (E
rowing of the left anterior descending coronary artery (wraps around the apex) duri
and resolution of both findings after intracoronary nitroglycerin (B). The lower pan
sion the patient had reproduction of chest pain and ischemic ECG changes but no
changes resolved (D). Please see the accompanying Online Video.ever, reported some chest pain (n 14), had ischemic ECGchanges (n  7), or had diffuse asymptomatic epicardial
narrowing 75% (n  8) during the test.
Univariate analysis revealed that, compared with patients
with a “negative” ACH test (n  47), those with evidence
of abnormal coronary vasomotion (n 77) were more likely
to be female. Furthermore, they more often had effort-
induced chest pain, and they also had a higher prevalence of
a positive family history for cardiovascular disease, com-
pared with patients with a “negative” ACH test (Table 3).
On multivariate analysis, the same variables (female gender,
effort-induced chest pain, and a positive family history) were
identified as significant independent predictors for abnor-
mal coronary vasomotion (Table 2). Because diabetes and
hypertension have long been recognized to be associated
with structural changes in the microvasculature, both vari-
ables were included into the multivariate analysis, although
they did not reach statistical significance on univariate
analysis. Moreover, the presence of both hypertension and
diabetes was tested. Either alone or in combination, these
a patient with epicardial spasm. Note the diffuse but distally accentuated nar-
tylcholine infusion together with ischemic ECG shifts in the inferior leads (A)
w an example of a patient with microvascular spasm. During acetylcholine infu-
rdial vasoconstriction (C). After intracoronary nitroglycerin, chest pain and ECGCGs) in
ng ace
els sho
epicavariables did not reach statistical significance in the multi-
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procedure.
No significant differences were found with regard to clinical
presentation and cardiovascular risk factors, when patients with
epicardial and microvascular spasm were compared.
Discussion
We found a high prevalence of patients with normal or
“near” normal coronary arteriograms among patients with
stable angina referred for diagnostic coronary angiography,
as previously reported by other investigators (1–3,14). The
novel finding in our study, however, is the high prevalence
of epicardial and coronary microvascular spasm in this group
of patients.
Patients with typical anginal symptoms and unobstructed
coronary arteries are usually considered by the treating
physician to have noncardiac chest pain or are sometimes
diagnosed as having microvascular angina, a condition
thought to be caused by a reduced vasodilatory ability of the
Clinical Characteristics in Study PatientsTable 1 Clinical Characteristics in Study Patients
All Patients
(N  283)
Male 137 (48%)
Age, yrs 66 10
Exertional chest pain pectoris 141 (50%)
Exertional dyspnea with occasional chest pain pectoris at rest 32 (11%)
Exertional chest pain with occasional symptoms at rest 110 (39%)
Noninvasive test for ischemia performed 240 (85%)
Ischemic ECG changes during noninvasive test for ischemia 151 (53%)
Risk factors
Hypertension 214 (76%)
Diabetes mellitus 66 (23%)
Hypertension and diabetes mellitus 55 (19%)
Hypercholesterolemia 191 (67%)
Smokers 38 (13%)
Positive family history for CVD 107 (38%)
Values are n (%) or mean  SD.
CAD  coronary artery disease; CVD  cardiovascular diseases; ECG  electrocardiographic.
Multivariate Logistic Regression AnalysisTable 2 Multivariate Logistic Regression Analysis
HR (95% CI) p Value
CAD vs. no CAD
Age 1.07 (1.03–1.11) 0.01
Male 5.82 (2.83–12.00) 0.01
Purely effort-induced chest pain 4.22 (2.21–8.05) 0.01
Ischemic ST-segment changes during
noninvasive exercise test
3.27 (1.65–6.50) 0.01
Hypercholesterolemia 3.80 (1.83–7.86) 0.01
Abnormal vs. normal coronary
vasomotor response
Female 3.20 (1.26–8.12) 0.014
Purely effort-induced chest pain 0.26 (0.09–0.78) 0.016
Positive family history for CVD 0.11 (0.04–0.30) 0.01Hazard ratios (HRs), 95% confidence intervals (CIs), and p values are presented.
CAD  coronary artery disease; CVD  cardiovascular diseases.coronary microcirculation (6). Microvascular spasm has
mainly been seen in Japanese patients where functional
testing is an integrated part of invasive coronary angiogra-
phy. It has been reported that microvascular spasm was less
common in Caucasian cohorts (5) but functional coronary
testing is not broadly applied in Europe or the United
States. However, in the present prospective study in a
contemporary European patient cohort referred for diagnos-
tic coronary angiography and found to have normal or near
normal coronary arteries, we observed microvascular spasm
in a large proportion of our patients. The results of our study
are of clinical importance, because we have shown for the
first time that both epicardial (mainly distal) and microvas-
cular spasm can be responsible for or associated with anginal
symptoms and ST-segment changes in a large proportion of
patients with stable angina and unobstructed coronary
arteries.
The observation in our study that patients with unob-
structed coronary arteries were more often women than men
is in line with previous work from Bell et al. (14), who
showed that, among 22,795 patients undergoing coronary
angiography, 24% of men and 48% of women had unob-
structed coronary arteries. Similar observations were made
in the large American College of Cardiology National
Cardiovascular Data Registry database of 565,504 patients
(3), where the median rate of obstructive CAD (any
epicardial stenosis 50%) was only 45%. Although one
cannot necessarily apply our results to such a large popula-
tion in the United States, one can still speculate about the
implications for the health care system if approximately 30%
to 50% of patients with anginal symptoms and unobstructed
coronary arteries would have a coronary vasomotor abnor-
mality as an explanation for their symptoms.
In both of the large studies quoted in the previous
paragraph, women were more likely than men to have
(>50% Coronary Stenosis)
(n  139 [49%])
Unobstructed Coronary Arteries
(n  144 [51%]) p Value
93 (67%) 44 (31%) 0.01
69 10 64 10 0.01
97 (70%) 44 (31%) 0.01
5 (4%) 27 (19%) 0.01
37 (27%) 73 (51%) 0.01
122 (88%) 118 (82%) 0.19
95 (68%) 56 (39%) 0.01
112 (81%) 102 (71%) 0.07
35 (25%) 31 (22%) 0.49
31 (22%) 24 (17%) 0.29
108 (78%) 83 (58%) 0.01
16 (12%) 22 (15%) 0.39
47 (34%) 60 (42%) 0.18CADunobstructed coronary arteries, despite the presence of
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among patients with unobstructed coronary arteries in our
study, women were also more often found to have abnormal
coronary vasomotion than men. To assess the potential
reasons for this was beyond the remit of our study, but this
is an issue that requires further investigation.
Our finding that a positive family history for cardiovas-
cular disease was more often present in patients with
abnormal coronary vasomotion compared with those with-
out is in line with previous studies (15), underpinning the
potential impact of the genetic background in the setting of
coronary vasomotor disorders. Various genetic mutations
have been described as potential explanations (16,17).
Previous studies have suggested a higher prevalence of
epicardial spasm among Asian compared with Caucasian
patients (18). However, recent studies on Caucasian pa-
tients have cast doubt on this discrepancy (19). The finding
of our study that 28% of patients with unobstructed coro-
nary arteries were found to have epicardial spasm is in line
with data from Asian patients (20) supporting the notion
that epicardial coronary spasm might be equally frequent in
Asian and Caucasian patients.
A puzzling finding in our study is that, even in the
subgroup of patients with purely effort-induced chest pain,
epicardial coronary spasm was elicited by ACH-injection
and was shown to reproduce the chest pain of the patient.
Exercise-induced epicardial coronary spasm has been previ-
ously reported by different authors (21–23). An increased
activity of the sympathetic autonomic nervous system cou-
pled with parasympathetic withdrawal during exercise and
leading to adrenergic alpha-receptor–induced epicardial
coronary spasm has been proposed as a potential explanation
Clinical Characteristics of Patients With Stable Angina, UnobstrucTable 3 Clinical Characteristics of Patients With Stable Angina
All Patients With
Unobstructed Coronary Arteries
(<20% Narrowings) and ACH Test
(n  124)
Age, yrs 63 10
Male 37 (30%)
Exertional chest pain 32 (26%)
Exertional dyspnea with
occasional chest pain at rest
25 (20%)
Exertional chest pain with
occasional symptoms at rest
67 (54%)
Noninvasive test for ischemia performed 102 (82%)
Ischemic ECG changes during
noninvasive test for ischemia
45 (36%)
Risk factors
Hypertension 86 (69%)
Diabetes mellitus 25 (20%)
Hypertension and diabetes mellitus 20 (16%)
Hypercholesterolemia 69 (56%)
Smokers 18 (15%)
Positive family history for CVD 55 (44%)
Values are n (%) or mean  SD. *p value refers to the comparison of all 3 patient groups.
ACH  acetylcholine; other abbreviations as in Table 1.(24). However, an alternative explanation for this findingcould be that ACH-provoked epicardial spasm is merely a
marker for the presence of an abnormal coronary vascular
tone preventing appropriate vasodilatation with exercise.
The finding that epicardial spasm was most often diffuse
and located in the distal segments of the coronary arteries and
that it was often preceded by ischemic ECG shifts and/or
reproduction of the symptoms of the patient (data not shown)
suggests that epicardial spasm in our patients often began with
microvascular spasm. This indicates that there is a spectrum
of coronary vasomotion in response to ACH ranging from
subtle changes via findings compatible with microvascular
spasm to severe distal and diffuse epicardial spasm (8).
Microvascular spasm has been described as a pathogenic
mechanism for resting chest pain in patients with normal
coronary angiograms, albeit mainly Japanese (5,25). The
high prevalence of microvascular spasm in the present study
suggests an important role of coronary microvascular dys-
function also as a possible cause of exercise-induced angina
in patients with chest pain and unobstructed coronary
arteries (26). Although microvascular dysfunction cannot be
visualized directly, it has been shown that abnormal coro-
nary vasomotion in response to ACH is associated with
perfusion defects on cardiac stress magnetic resonance
imaging with adenosine (27). Moreover, impaired micro-
vascular reactivity to adenosine has been shown to be
predictive of major adverse outcomes among women eval-
uated for suspected ischemia (28), underpinning the prog-
nostic implications of microvascular dysfunction.
That microvascular spasm was demonstrated in patients
with effort-induced anginal symptoms indicates that abnor-
mal microvascular vasomotion might be triggered by phys-
ical exercise. It is conceivable that the full spectrum of
oronary Arteries (<20% Narrowings) and ACH Testbstructed Coronary Arteries (<20% Narrowings) and ACH Test
ardial Spasm
 35 [28%])
Microvascular Spasm
(n  42 [34%])
ACH Test Uneventful
(n  47 [38%]) p Value*
65 11 64 11 62 9 0.32
8 (23%) 7 (17%) 22 (47%) 0.01
14 (40%) 11 (26%) 7 (15%) 0.04
3 (9%) 10 (24%) 12 (26%) 0.13
18 (51%) 21 (50%) 28 (60%) 0.64
28 (80%) 35 (83%) 39 (83%) 0.91
9 (26%) 21 (50%) 15 (32%) 0.06
21 (60%) 32 (76%) 33 (70%) 0.30
5 (14%) 8 (19%) 12 (26%) 0.48
4 (11%) 7 (17%) 9 (19%) 0.65
17 (49%) 24 (57%) 28 (60%) 0.60
4 (11%) 3 (7%) 11 (23%) 0.09
20 (57%) 28 (67%) 7 (15%) 0.01ted C, Uno
Epic
(nabnormal coronary vasomotion operates in these patients
661JACC Vol. 59, No. 7, 2012 Ong et al.
February 14, 2012:655–62 Pathological ACH Response in Stable Angina(i.e., a background of endothelial and/or medial smooth
muscle dysfunction involving the whole coronary tree,
which can lead to severe coronary constriction in response to
a diversity of stimuli, including exercise, anxiety, and yet
unidentified triggers).
Intracoronary ACH provocation testing has been re-
ported to be a sensitive and safe test for the assessment of
coronary vasomotor function in the catheterization labora-
tory (29). A stepwise infusion approach with incremental
doses, as in the present study, ensures a very low rate of
serious complications (1%) (30), which is in the order
reported for diagnostic coronary angiography (31). With
such a protocol, the infusion of ACH did not result in any
serious complications in more than 2,500 such tests per-
formed at our institution since 2006.
Clinical implications of our findings. The high preva-
lence of epicardial and microvascular coronary spasm in our
study suggests that functional abnormalities of the coronary
arteries should regularly be considered as a differential
diagnosis in patients with stable angina but angiographically
unobstructed coronary arteries. Moreover, they should be
suspected especially in female patients with effort-induced
chest pain, a positive family history for cardiovascular
disease, and coronary arteriograms with only minimal irreg-
ularities. Intracoronary provocation tests (e.g., with ACH)
might represent a useful clinical tool to establish the
diagnosis of a functional abnormality underlying the symp-
toms of the patient. Such a diagnostic algorithm might also
represent a cost-effective approach, minimizing the need for
repeated invasive and noninvasive tests for myocardial isch-
emia and CAD commonly performed in this type of patient
in the attempt to establish a diagnosis, which often proves
elusive (32,33).
Study limitations. We focused, for inclusion in the study,
on patients with exercise-related anginal symptoms, but an
abnormal exercise stress test was not required. This might
have led to different results with regard to the prevalence of
unobstructed coronary arteries and abnormal coronary va-
somotion on ACH testing. However, the aim of our study
was to assess a representative real-world clinical cohort of
patients, and it is common practice that patients with
exertional chest pain and cardiovascular risk factors undergo
coronary angiography without noninvasive testing for tran-
sient myocardial ischemia (34).
For the administration of ACH, we used the same
protocol as in the ENCORE II (Evaluation of Nifedipine
and Cerivastatin on the Recovery of Endothelial Function)
study (11), with the exception that, whereas investigators in
the ENCORE II study selectively injected incremental
ACH doses of 2, 20, and 100 g into the left anterior
descending and left circumflex arteries, respectively, we
administered graded doses of ACH through the diagnostic
catheter into the left main stem, with a maximum dose of
200 g. This slight modification of the protocol was carried
out for logistic reasons (to avoid instrumentation of thecoronary vessels) and is unlikely to have resulted in major
differences in the coronary responses.
Because direct visualization of the coronary microcircu-
lation in the clinical setting is not possible at present,
microvascular spasm remains a diagnosis of exclusion. How-
ever, we used an accepted definition of microvascular spasm
as proposed by Mohri et al. (5). Due to the paucity of data
with regard to coronary microvascular spasm, the definition
by Mohri et al. (5) has not been validated in larger trials.
However, according to our experience, this definition is
practically useful when performing ACH provocation test-
ing, because the response described by Mohri et al. (5) is
frequently encountered. Furthermore, the fact that a path-
ological ACH test result is associated with perfusion defects
on cardiac stress magnetic resonance imaging (27) under-
lines the ischemic origin of such disorders.
Conclusions
Nearly 50% of patients undergoing diagnostic angiography
for the assessment of stable angina had angiographically
unobstructed coronary arteries. Intracoronary ACH provo-
cation triggered epicardial as well as microvascular coronary
spasm leading to reproduction of the symptoms of the
patient combined with ischemic ST-segment changes in
nearly two-thirds of these patients. Our results suggest that
intracoronary ACH provocation might be a useful clinical
tool for the assessment of patients with suspected CAD who
are found to have unobstructed coronary arteries.
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